The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...

IRA’s $2,000 out-of-pocket cap helps few; most won’t hit the threshold Insurers raise deductibles, replace flat co-pays with ...

CMS’ drug price negotiations are advancing, but new indications and exclusivity rules could complicate future pricing cycles. CMS gained the authority to negotiate list prices with drug manufacturers ...

Senate Republicans released their version of the Trump administration’s “One Big Beautiful Bill Act” on Monday with a few ...

The Inflation Reduction Act (IRA), signed into law in August 2022, marked a historic shift in US healthcare policy by ...

Health policy experts say the tariffs would raise prices for patients, potentially disrupt supply, and could hurt the US ...

Mehmet Oz recently took the reins as the new head of the Centers for Medicare & Medicaid Services (CMS), which oversees health coverage for nearly half of Americans. He will ...

Launch prices for anticancer drugs covered under Medicare Part D continue to rise, even with recent Inflation Reduction Act ...

The Centers for Medicare & Medicaid Services recently began meeting with patients who use the 15 drugs it selected for the ...

President Donald Trump’s proposal to peg American drug costs to prices paid in other countries risks upending Medicaid’s drug ...